Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat-containing protein 38 (LRRC38) is a membrane protein that acts as an **auxiliary gamma subunit (γ4)** for the large-conductance, voltage- and calcium-activated potassium (BK) channel. LRRC38 is part of the leucine-rich repeat (LRR) protein superfamily and forms a group of BK channel auxiliary proteins termed the gamma subunits, which also includes LRRC26 (γ1), LRRC52 (γ2), and LRRC55 (γ3)[1][2][3][4]. Unlike the classic β subunits, these gamma subunits are structurally distinct, containing an N-terminal signal peptide, an extracellular LRR domain, a single transmembrane segment, and a short intracellular C-terminal tail[3]. LRRC38 is able to co-assemble with BK channel alpha subunits and modulate their activation by shifting the voltage dependence toward more negative potentials, albeit to a smaller extent (about −20 mV in absence of calcium) than other gamma subunits[1][2][3][4]. LRRC38 is mainly expressed in secretory glands and plays a role in tissue-specific regulation of BK channel gating properties, likely contributing to the functional diversity of BK channels in different cell types[2]. Direct drug interactions, disease roles, and use as a biomarker have not been established for LRRC38 as of the current literature[2][4].
LRRC38 itself does not have known small-molecule modulators; it modulates BK channel gating by association with the BK channel alpha subunit, affecting voltage dependence and channel kinetics[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat-containing protein 38 (LRRC38).